QQ客服 官方微博 反馈留言

	Discovery of 2-(aminopyrimidin-5-yl)-4-(morpholin-4-yl)-6- substituted triazine as PI3K and BRAF dual inhibitor.
	Wang Hui-Yan; Shen Ying; Zhang Hao; Hei Yuan-Yuan; Zhao Hong-Yi; Xin Minhang; Lu She-Min; Zhang San-Qi
刊名	Future medicinal chemistry
	2018
卷号	10页码:2445-2455
关键词	BRAF inhibitor drug design PI3K inhibitor antiproliferative effects PI3K and BRAF dual inhibitor
ISSN号	1756-8927
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2830852
专题	西安交通大学
推荐引用方式 GB/T 7714	Wang Hui-Yan,Shen Ying,Zhang Hao,et al. Discovery of 2-(aminopyrimidin-5-yl)-4-(morpholin-4-yl)-6- substituted triazine as PI3K and BRAF dual inhibitor.[J]. Future medicinal chemistry,2018,10:2445-2455.
APA	Wang Hui-Yan.,Shen Ying.,Zhang Hao.,Hei Yuan-Yuan.,Zhao Hong-Yi.,...&Zhang San-Qi.(2018).Discovery of 2-(aminopyrimidin-5-yl)-4-(morpholin-4-yl)-6- substituted triazine as PI3K and BRAF dual inhibitor..Future medicinal chemistry,10,2445-2455.
MLA	Wang Hui-Yan,et al."Discovery of 2-(aminopyrimidin-5-yl)-4-(morpholin-4-yl)-6- substituted triazine as PI3K and BRAF dual inhibitor.".Future medicinal chemistry 10(2018):2445-2455.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。